TY - INPR A1 - Döring, Sarah A1 - Weller, Michael G. A1 - Reinders, Yvonne A1 - Konthur, Zoltán A1 - Jaeger, Carsten T1 - Challenges and Insights in Absolute Quantification of Recombinant Therapeutic Antibodies by Mass Spectrometry: An Introductory Review N2 - This review describes mass spectrometry (MS)-based approaches for the absolute quantification of therapeutic monoclonal antibodies (mAbs), focusing on technical challenges in sample treatment and calibration. Therapeutic mAbs are crucial for treating cancer, inflammatory, infectious, and autoimmune diseases. We trace their development from hybridoma technology and the first murine mAbs in 1975 to today’s chimeric and fully human mAbs. With increasing commercial relevance, absolute quantification of mAbs, traceable to SI units, has attracted attention from science, industry, and national metrology institutes (NMIs). Quantification of proteotypic peptides after enzymatic digestion using liquid chromatography-tandem mass spectrometry (LC-MS/MS) has emerged as the most viable strategy, though methods targeting intact mAbs are still being explored. We review peptide-based quantification, focusing on critical experimental steps like denaturation, reduction, alkylation, choice of digestion enzyme, and selection of signature peptides. Challenges in amino acid analysis (AAA) for quantifying pure mAbs and peptide calibrators, along with software tools for targeted MS data analysis, are also discussed. Short explanations within each chapter provide newcomers an overview of the field’s challenges. Finally, we discuss prospects and limitations of developing standardized protocols and certified reference materials (CRMs) and suggest future applications of newer technologies for the absolute quantification of therapeutic antibodies. KW - Antibody KW - Mass spectrometry KW - Absolute quantification KW - Metrology KW - Reference products PY - 2024 UR - https://nbn-resolving.org/urn:nbn:de:kobv:b43-621841 DO - https://doi.org/10.20944/preprints202412.1081.v1 SP - 1 EP - 22 PB - MDPI AN - OPUS4-62184 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - INPR A1 - Döring, Sarah A1 - Wulfes, Birte S. A1 - Atanasova, Aleksandra A1 - Jaeger, Carsten A1 - Walzel, Leopold A1 - Tscheuschner, Georg A1 - Flemig, Sabine A1 - Gawlitza, Kornelia A1 - Feldmann, Ines A1 - Konthur, Zoltán A1 - Weller, Michael G. T1 - Corundum Particles as Trypsin Carrier for Efficient Protein Digestion N2 - Reusable enzyme carriers are valuable for proteomic workflows, yet many supports are expensive or lack robustness. This study describes the covalent immobilization of recombinant trypsin on micrometer-sized corundum particles and assesses their performance in protein digestion and antibody analysis. The corundum surface was cleaned with potassium hydroxide, silanized with 3-aminopropyltriethoxysilane and activated with glutaraldehyde. Recombinant trypsin was then attached, and the resulting imines were reduced with sodium cyanoborohydride. Aromatic amino acid analysis (AAAA) estimated an enzyme loading of approximately 1 µg/mg. Non-specific adsorption of human plasma proteins was suppressed by blocking residual aldehydes with a Tris-glycine-lysine buffer. Compared with free trypsin, immobilization shifted the temperature optimum from 50 to 60 °C and greatly improved stability in 1 M guanidinium hydrochloride. Activity remained above 80 % across several reuse cycles, and storage at 4 °C preserved functionality for weeks. When applied to digesting the NISTmAb, immobilized trypsin provided peptide yields and sequence coverage comparable to soluble enzyme and outperformed it at elevated temperatures. MALDI-TOF MS analysis of Herceptin digests yielded fingerprint spectra that correctly identified the antibody and achieved >60 % sequence coverage. The combination of low cost, robustness and analytical performance makes corundum-immobilized trypsin an attractive option for research and routine proteomic workflows. KW - Aluminum oxide KW - Mass spectrometry KW - Enzyme immobilization KW - Antibodies KW - Protein quantification PY - 2025 UR - https://nbn-resolving.org/urn:nbn:de:kobv:b43-647944 DO - https://doi.org/10.20944/preprints202510.2002.v1 SP - 1 EP - 22 PB - Preprints.org AN - OPUS4-64794 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - INPR A1 - Tannenberg, Robert A1 - Tscheuschner, Georg A1 - Raab, Christopher A1 - Flemig, Sabine A1 - Döring, Sarah A1 - Ponader, Marco A1 - Thurmann, Melinda A1 - Paul, Martin A1 - Weller, Michael G. T1 - Simplified Sample Preparation and Lateral Flow Immunoassay for the Detection of Plant Viruses N2 - Lateral flow immunoassays (LFA) are widely used for decentralized testing, but their application for in-field plant virus diagnostics is often limited by tedious sample preparation. Here, we present a simplified dipstick LFA for the detection and monitoring of cowpea chlorotic mottle virus (CCMV) as a model plant pathogen. The assay employes a monoclonal mouse antibody for capture and a polyclonal rabbit antibody conjugated to 80-nm gold nanoparticles for detection. Conventional sample and conjugate pads are omitted, allowing the test strips to be dipped directly into wells containing plant extract and antibody-gold conjugate. In addition, no plastic casing was necessary, which significantly reduces waste. It was shown that CCMV concentrations as low as 4 μg/L or 400 pg per sample could be reliably detected in 15 minutes. Specificity tests confirmed that other plant viruses, cowpea mosaic virus (CPMV) and tobacco mosaic virus (TMV), did not produce false positive results. Furthermore, we describe a field-compatible sampling procedure using a manual punch and a disposable syringe. This step combines sample grinding, extraction, and conjugate reconstitution within the syringe frit, enabling the analysis of punched leaf discs without laboratory equipment. When applied to CCMV-infected cowpea plants, the assay revealed systemic infection before visual symptoms became apparent. This work demonstrates that simplified LFAs combined with innovative sampling techniques can provide sensitive, specific, and rapid diagnostics for crop monitoring and support early intervention strategies in agriculture. N2 - Lateral Flow Immunoassays (LFA) werden häufig für dezentrale Tests verwendet, aber ihre Anwendung für die Diagnose von Pflanzenviren im Feld wird oft durch die mühsame Probenvorbereitung eingeschränkt. Hier stellen wir einen vereinfachten Dipstick-LFA zum Nachweis und zur Überwachung des Cowpea Chlorotic Mottle Virus (CCMV) als Modellpflanzenpathogen vor. Der Assay verwendet einen monoklonalen Maus-Antikörper zum Einfangen des Virus und einen polyklonalen Kaninchen-Antikörper, der an 80-nm-Goldnanopartikel konjugiert ist, zum Nachweis. Herkömmliche Proben- und Konjugatpads entfallen, sodass die Teststreifen direkt in Vertiefungen getaucht werden können, die Pflanzenextrakt und Antikörper-Gold-Konjugat enthalten. Darüber hinaus war keine Kunststoffhülle erforderlich, was den Abfall erheblich reduziert. Es zeigte sich, dass CCMV-Konzentrationen von nur 4 μg/L oder 400 pg pro Probe innerhalb von 15 Minuten zuverlässig nachgewiesen werden konnten. Spezifitätstests bestätigten, dass andere Pflanzenviren, das Cowpea Mosaic Virus (CPMV) und das Tobacco Mosaic Virus (TMV), keine falsch positiven Ergebnisse lieferten. Darüber hinaus beschreiben wir ein feldtaugliches Probenahmeverfahren unter Verwendung eines manuellen Stanzers und einer Einwegspritze. Dieser Schritt kombiniert das Zerkleinern der Probe, die Extraktion und die Rekonstitution des Konjugats innerhalb der Spritzenfritte und ermöglicht so die Analyse von ausgestanzten Blattscheiben ohne Laborausrüstung. Bei der Anwendung auf CCMV-infizierte Augenbohnenpflanzen zeigte der Test eine systemische Infektion, bevor visuelle Symptome sichtbar wurden. Diese Arbeit zeigt, dass vereinfachte LFAs in Kombination mit innovativen Probenahmetechniken eine sensitive, spezifische und schnelle Diagnostik für die Überwachung von Nutzpflanzen ermöglichen und frühzeitige Interventionsstrategien in der Landwirtschaft unterstützen können. KW - Vigna unguiculata KW - Cowpea KW - Sample preparation KW - Plant pathogen KW - Mobile detection KW - Crop monitoring KW - Plastic waste KW - Lateral flow immunoassay KW - Plant virus KW - Sample pad KW - Conjugate pad PY - 2025 UR - https://nbn-resolving.org/urn:nbn:de:kobv:b43-651731 DO - https://doi.org/10.20944/preprints202512.1492.v1 SP - 1 EP - 14 PB - MDPI CY - Basle, Switzerland AN - OPUS4-65173 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - CONF A1 - Döring, Sarah T1 - Novel Trypsin-functionalized Corundum Particles for Improved Antibody Digestion N2 - Therapeutic monoclonal antibodies are the fastest-growing class of biological agents and the development of reliable analytical methods for their quantification is becoming increasingly important. Liquid chromatography coupled with tandem mass spectrometry (LC–MS/MS) represents one of the leading technologies for antibody quantification. The serin protease trypsin has emerged as the gold standard enzyme for digesting intact protein into peptides for this approach. However, many protocols exist that often lead to different results. However, many protocols exist that often lead to different results depending on the digestion procedure. In particular, the type and amounts of detergents added during sample preparation for protein unfolding before digestion is known to create undesirable structure modifications of proteins (e.g. carbamylation) and significant bias in measurement results by inhibiting enzyme activity. The source and nature of the enzyme itself can also have an influence, whereby immobilized variants are increasingly being used to improve their stability, minimize self-digestion and enable a higher substrate-enzyme ratio. Here, we explored the potential of a novel thermostable trypsin and surface-functionalized corundum particles for enhanced antibody digestion. For this purpose, the inactive proenzym was recombinantly produced in inclusion bodies of E. coli and successfully folded back into functional conformation via multi-stage dialysis using a cysteine-cystine redox system. After cleavage of the propeptide and purification of active variants, enzyme activity was comparable to commercially available trypsin product. In addition, produced trypsin showed increased thermal stability under typical digestion conditions compared to reference product. In solution digestion experiments of antibody have revealed that the thermostable variant demonstrates enhanced digestive efficacy compared to the wild type. Furthermore, APTES-silanization followed by polymerization of corundum surface prevent nonspecific protein adsorption during the protein digestion procedure and the immobilized enzyme still showed substrate activity after covalent binding. Compared to wild-type and a non-immobilized enzyme, the surface-functionalized thermostable variant showed increased activity at temperatures above 80°C. Thus, this novel type of trypsin particles promises to not only improve antibody digestion at high temperatures, but also to prevent self-digestion and enable the separation of trypsin from target peptides in LC–MS analysis. T2 - Adlershofer Forschungsforum CY - Berlin, Germany DA - 11.11.2024 KW - Antibody Quantification KW - Corundum KW - Enzyme Immobilization KW - LC-MS/MS PY - 2024 AN - OPUS4-61680 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - GEN A1 - Tchipilov, Teodor A1 - Raysyan, Anna A1 - Weller, Michael G. T1 - Methods for the quantification of particle-bound protein – Application to reagents for lateral-flow immunoassays (LFIA) N2 - Protein immobilization for the functionalization of particles is used in various applications, including biosensors, lateral-flow immunoassays (LFIA), bead-based assays, and others. Common methods for the quantification of bound protein are measuring protein in the supernatant before and after coating and calculating the difference. This popular approach has the potential for a significant overestimation of the amount of immobilized protein since layers not directly bound to the surface (soft protein corona) are usually lost during washing and handling. Only the layer directly bound to the surface (hard corona) can be used in subsequent assays. A simplified amino acid analysis method based on acidic hydrolysis and RP-HPLC-FLD of tyrosine and phenylalanine (aromatic amino acid analysis, AAAA) is proposed to directly quantify protein bound to the surface of gold nano- and latex microparticles. The results are compared with indirect methods such as colorimetric protein assays, such as Bradford, bicinchoninic acid (BCA), as well as AAAA of the supernatant. For both particle types, these indirect quantification techniques show a protein overestimation of up to 1700% compared to the direct AAAA measurements. In addition, protein coating on latex particles was performed both passively through adsorption and covalently through EDC/sulfo-NHS chemistry. Our results showed no difference between the immobilization methodologies. This finding suggests that usual protein determination methods are no unambiguous proof of a covalent conjugation on particles or beads. KW - Soft protein corona KW - Hard protein corona KW - Gold particles KW - Nanoparticles KW - Mikroparticles KW - Antibody KW - Bioconjugation KW - Protein quantification KW - Supernatant KW - Sodium chloride method KW - Covalent conjugation KW - Latex particles KW - Lateral flow immunoassays PY - 2022 UR - https://nbn-resolving.org/urn:nbn:de:kobv:b43-545365 DO - https://doi.org/10.20944/preprints202203.0332.v1 SP - 1 EP - 8 PB - MDPI CY - Basel AN - OPUS4-54536 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - GEN A1 - Hiller, Lukas T1 - Herstellung und Charakterisierung eines rekombinanten Anti-Tetanus-Antikörpers aus verschiedenen Säugerzelllinien N2 - Antikörper sind in der medizinischen Welt nicht mehr wegzudenken. Ihr Einsatz-Repertoire als Therapeutika für die Behandlung diverser Krankheiten und Infektionen weitet sich von Jahr zu Jahr mehr aus. Dabei basiert ein Großteil der verwendeten Antikörper zu diesem Zeitpunkt auf monoklonalen Antikörpern auf Basis von Hybridomazellen. Doch hier könnten rekombinante Antikörper aufgrund ihrer Vektor-basierten Expression eine vielversprechende und womöglich sogar revolutionierende Alternative bieten. So ergeben sich neue Optimierungsoptionen für Merkmale wie Affinität, Stabilität und Kompatibilität über Anpassungen auf genetischer oder posttranslationaler Ebene. Allerdings ergibt sich kein Anwendungszweck ohne die vorhergehende detaillierte Charakterisierung der Antikörper. Denn nur mit spezifischem Wissen über die diversen Eigenschaften und Wechselwirkungen kann eine effektive und präzise Verwendung in der Diagnostik und Therapeutik gewährleistet werden und auf diese Weise Leben retten. Aus diesem Grund beschäftigt sich diese Masterarbeit mit der Vertiefung der rekombinanten Antikörper-Thematik. Dazu soll ein Anti-Tetanus-Antikörper erstmals rekombinant in verschiedenen Zelllinien hergestellt und anschließend über umfangreiche analytische Verfahren mit einem Fokus auf die Einflussanalyse der unterschiedlichen posttranslationalen Glykosylierungen charakterisiert werden. Zu diesem Zweck wurden als Grundlage einerseits zwei P1316-Dual-Expressions-Vektoren mit variierenden Insert-Positionen der schweren und leichten Kette durch Gibson-Assembly sowie individuellen pRK5-Plasmide für eine separiert Expression der Antikkörperketten mithilfe Restriktionsfragment-Ligation generiert. In einer Gegenüberstellung der der Expressionsausbeuten stellte sich die Überlegenheit der P1316-Plasmid-Konfiguration heraus, in der das Leichtketten-Insert an der ersten Expressionsstelle positioniert ist. Deshalb wurde dieser Vektor als Ausgangspunkt für die anschließende hochskalierten Herstellung des Anti-Tetanus-Antikörpers in Expi293F-GnTI- und ExpiCHO-S-Zellen verwendet. Ein ELISA bestätigte die Bindungsaktivität der rekombinanten Antikörper am Tetanus-Toxoid unabhängig vom Expressionssystem. Nach einer folgenden Optimierung der für die Aufreinigung verwendeten Protein-A-Affinitätschromatographie, wurde über weitere Charakterisierungsmethoden wie Größenausschlusschromatographie und dynamische Lichtstreuung eine vergleichbare Aggregation aufgrund der sauren Elution aufgezeigt. In diesem Kontext wurde die Notwendigkeit einer Zweistufen-Präparation mit Affinitäts- und Größenausschlusschromatografie für den Erhalt monodisperser Proben verdeutlicht. Zudem wurden die verschiedenen intakten Massen mitsamt ihrer spezifischen Glykan-abhängigen Streumaßen in Relation zum monoklonalen NISTmAB-Referenzantikörper bestimmt. Dabei konnte den Erwartungen nach sowohl die geringere Masse als auch die uniformere Glykosylierung der in Expi293 GnTI- exprimierten Immunoglobuline in Relation zum ExpiCHO-S-Antikörper nachgewiesen werden. Anschließend wurde das Stabilitätsverhalten mittels thermischer Entfaltung und dynamischer Lichtstreuung über einen ausgeweiteten Zeitraum sowie verschiedenen Temperaturen dokumentiert. Grundlegend wurde eine höhere thermische Stabilität der zweiten konstanten Schwerketten-Domäne des aus ExpiCHO-S-Zellen stammenden Antikörpers nachgewiesen. Außerdem konnte eine problemlose Lagerungsfähigkeit beider unterschiedlich glykosylierter Antikörper bei Raumtemperatur für mindestens 4 Wochen festgestellt werden. Des Weiteren wurde die Langzeitlagerung im Rahmen der Auswirkung von Gefrier-Auftau-Zyklen mit gleichbleibenden Methoden sowie zusätzlicher Größenausschlusschromatographie erprobt. Hierbei stellte sich der Erhalt der strukturellen Integrität nach bis zu 15 Zyklen heraus. Allerdings geht die Monodispersität bereits nach wenigen Zyklen verloren, wobei die geringfügiger glykosylierten Expi293F-GnTI-Anti-Tetanus-Antikörper eine stärkere Beeinträchtigung durch multiple Gefrier-Auftau-Zyklen aufwiesen. KW - Rekombinante Antikörper KW - Affinitätschromatographie KW - Größenausschlusschromatographie KW - MALDI-TOF-MS KW - Dynamische Lichtstreuung PY - 2024 SP - 1 EP - 120 CY - Berlin AN - OPUS4-59865 LA - deu AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - GEN A1 - Döring, Sarah T1 - Corundum Particles as Trypsin Carrier for Efficient Protein Digestion N2 - This dataset contains raw LC–MS/MS files of trypsin-digested NISTmAb acquired on a SCIEX TripleTOF 6600 mass spectrometer in DIA (SWATH) mode for antibody quantification. In addition, it includes MALDI-TOF MS peptide mass fingerprints of trypsin-digested Herceptin as well as reference spectra that can be used for antibody identification using the open-source software ABID 2.0 (https://bam.de/ABID). The data were generated within a study demonstrating the applicability of corundum-immobilized trypsin for antibody digestion and its suitability for peptide-based LC–MS/MS quantification and MALDI-TOF MS fingerprinting–based antibody identification. KW - NISTmAb KW - Herceptin KW - MALDI-TOF MS peptide mass fingerprint KW - ABID 2.0 PY - 2025 DO - https://doi.org/10.5281/zenodo.17416536 PB - Zenodo CY - Geneva AN - OPUS4-65365 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - GEN A1 - Döring, Sarah T1 - Vergleichende Darstellung SARS-CoV-2-spezifischer Nanobodys aus unterschiedlichen Wirtsorganismen N2 - Aufgrund der anhaltenden COVID-19-Pandemie werden neutralisierende Therapeutika benötigt. Eine Möglichkeit zur Behandlung stellt die Verwendung monoklonaler Anti-SARS-CoV-2-Immun-globuline dar. Ihre Produktion in Säugetierzellen ist jedoch schwer skalierbar, um den weltweiten Bedarf zu decken. VHH-Antikörper, auch Nanobodys genannt, bieten hierfür eine Alternative, da sie eine hohe Temperaturstabilität aufweisen und eine kostengünstige Produktion in prokaryotischen Wirtsorganismen ermöglichen. KW - E. coli KW - Corona KW - Virus KW - Spike-Protein KW - Nanobody KW - Antikörper KW - Expression KW - Fingerprint KW - Vhh KW - RBD KW - COVID-19 KW - SARS-CoV-2 KW - ELISA KW - MST KW - Halomonas elongata KW - Periplasma KW - SDS-PAGE KW - ACE2-Rezeptor PY - 2021 SP - 1 EP - 111 PB - Technische Universität Berlin CY - Berlin AN - OPUS4-54624 LA - deu AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - JOUR A1 - Mi, W. A1 - Josephs, R. D. A1 - Melanson, J. E. A1 - Dai, X. A1 - Wang, Y. A1 - Zhai, R. A1 - Chu, Z. A1 - Fang, X. A1 - Thibeault, M.-P. A1 - Stocks, B. B. A1 - Meija, J. A1 - Bedu, M. A1 - Martos, G. A1 - Westwood, S. A1 - Wielgosz, R. I. A1 - Liu, Q. A1 - Teo, T. L. A1 - Liu, H. A1 - Tan, Y. J. A1 - Öztuğ, M. A1 - Saban, E. A1 - Kinumi, T. A1 - Saikusa, K. A1 - Schneider, Rudolf A1 - Weller, Michael G. A1 - Konthur, Zoltán A1 - Jaeger, Carsten A1 - Quaglia, M. A1 - Mussell, C. A1 - Drinkwater, G. A1 - Giangrande, C. A1 - Vaneeckhoutte, H. A1 - Boeuf, A. A1 - Delatour, V. A1 - Lee, J. E. A1 - O'Connor, G. A1 - Ohlendorf, R. A1 - Henrion, A. A1 - Beltrão, P. J. A1 - Naressi Scapin, S. M. A1 - Sade, Y. B. T1 - PAWG Pilot Study on Quantification of SARS-CoV-2 Monoclonal Antibody - Part 1 N2 - Under the auspices of the Protein Analysis Working Group (PAWG) of the Comité Consultatif pour la Quantité de Matière (CCQM) a pilot study, CCQM-P216, was coordinated by the Chinese National Institute of Metrology (NIM), National Research Council of Canada (NRC) and the Bureau International des Poids et Mesures (BIPM). Eleven Metrology Institutes or Designated Institutes and the BIPM participated in the first phase of the pilot study (Part 1). The purpose of this pilot study was to develop measurement capabilities for larger proteins using a recombinant humanized IgG monoclonal antibody against Spike glycoprotein of SARS-CoV-2 (Anti-S IgG mAb) in solution. The first phase of the study was designed to employ established methods that had been previously studies by the CCQM Protein Analysis Working Group, involving the digestion of protein down to the peptide or amino acid level. The global coronavirus pandemic has also led to increased focus on antibody quantitation methods. IgG are among the immunoglobulins produced by the immune system to provide protection against SARS-CoV-2. Anti-SARS-CoV-2 IgG can therefore be detected in samples from affected patients. Antibody tests can show whether a person has been exposed to the SARS-CoV-2, and whether or not they potentially show lasting immunity to the disease. With the constant spread of the virus and the high pressure of re-opening economies, antibody testing plays a critical role in the fight against COVID-19 by helping healthcare professionals to identify individuals who have developed an immune response, either via vaccination or exposure to the virus. Many countries have launched large-scale antibody testing for COVID-19. The development of measurement standards for the antibody detection of SARS-CoV-2 is critically important to deal with the challenges of the COVID-19 pandemic. In this study, the SARS-CoV-2 monoclonal antibody is being used as a model system to build capacity in methods that can be used in antibody quantification. Amino acid reference values with corresponding expanded uncertainty of 36.10 ± 1.55 mg/kg, 38.75 ± 1.45 mg/kg, 18.46 ± 0.78 mg/kg, 16.20 ± 0.67 mg/kg and 30.61 ± 1.30 mg/kg have been established for leucine, valine, phenylalanine, isoleucine and proline, respectively. Agreement between nearly all laboratories was achieved for the amino acid analysis within 2 to 2.5 %, with one participant achieving markedly higher results due to a technical issue found in their procedure; this result was thus excluded from the reference value calculations. The relatively good agreement within a laboratory between different amino acids was not dissimilar to previous results for peptides or small proteins, indicating that factors such as hydrolysis conditions and calibration procedures could be the largest sources of variability. Peptide reference values with corresponding expanded uncertainty of 4.99 ± 0.28 mg/kg and 6.83 ± 0.65 mg/kg have been established for ALPAPIEK and GPSVFPLAPSSK, respectively. Not surprisingly due to prior knowledge from previous studies on peptide quantitation, agreement between laboratories for the peptide-based analysis was slightly poorer at 3 to 5 %, with one laboratory's result excluded for the peptide GPSVFPLAPSSK. Again, this level of agreement was not significantly poorer than that achieved in previous studies with smaller or less complex proteins. To reach the main text of this paper, click on Final Report. KW - Antibody quantification KW - Amino acid analysis KW - Peptide analysis KW - Round robin test PY - 2021 DO - https://doi.org/10.1088/0026-1394/59/1a/08001 VL - 59 IS - 1A SP - 08001 AN - OPUS4-54972 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - JOUR A1 - Weller, Michael G. A1 - Schneider, Rudolf A1 - Rurack, Knut T1 - Mit dem Testsystem zur Probe N2 - (Bio)chemische Sensoren ersetzen bei der Vor-Ort-Analytik die großen Messgeräte oder dienen dazu, Analyten im Verdachtsfall oder kontinuierlich zu überwachen. Das können pharmazeutische Stoffe im Abwasser sein, Aflatoxin in Milch oder Sprengstoff am Flughafen. Ein Überblick über Neuentwicklungen. KW - Biochemische Sensoren KW - Vor-Ort-Analytik KW - Schnelltests KW - Antikörper PY - 2021 DO - https://doi.org/10.1002/nadc.20214112170 VL - 69 IS - 10 SP - 71 EP - 74 PB - Wiley-VCH CY - Weinheim AN - OPUS4-54003 LA - deu AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - GEN A1 - Atanasova, Aleksandra T1 - Herstellung und Einsatz neuartiger Trypsin-Partikel für den enzymatischen Antikörper-Verdau N2 - In dieser Arbeit wurden zwei Trypsinvarianten, der Wildtyp (wtT) und eine thermostabile Variante (tsT), rekombinant hergestellt. Die Herstellung von Proteinen in Bakterien kann zu Fehlfaltungen und Einschlusskörperchen führen, weshalb eine geeignete Faltungsstrategie notwendig ist. In dieser Arbeit konnte eine schrittweise Vorgehensweise erfolgreich angewendet werden. Nach der Ni-NTA-Aufreinigung wurde zusätzlich eine substratspezifische Benzamidin-Aufreinigung eingesetzt, um die Aktivität zu verbessern. Außerdem wurden die rekombinanten Trypsine auf Korund immobilisiert. Korund ist ein kostengünstiges Material, das nach Silanisierung und Glutaraldehyd-Kopplung für die Bindung von Proteinen geeignet gemacht wurde. Dabei konnte gezeigt werden, dass mehr wtT als tsT gebunden wurde, was sich auch in den Kopplungsdichte widerspiegelte. Die immobilisierten Enzyme wurden in Bezug auf Aktivität, Wiederverwendbarkeit, Lagerfähigkeit und Temperaturstabilität untersucht. Beide Varianten zeigten vergleichbare Leistungen, wobei tsT bei höheren Temperaturen eine etwas bessere Stabilität aufwies. Für den Antikörperverdau wurden sowohl thermische als auch chemische Denaturierungen bei verschiedenen Temperaturen ( 37 °C und 60 °C) getestet. Die Analyse mit MALDI-TOF-MS zeigte, dass gute Werte für die Sequenzabdeckung erzielt werden konnten. Besonders die chemische Denaturierung führte zu besseren Ergebnissen mit weniger Selbstverdau. Beim Vergleich mit kommerziell immobilisiertem Crude-Trypsin zeigten die rekombinanten Varianten eine höhere Spezifität und bessere Sequenzabdeckung bei gleichzeitig geringerem Selbstverdau. Die Wiederverwendbarkeit wurde durch fünf Verdauzyklen bei 37 °C überprüft. Dabei blieb die Aktivität weitgehend stabil, auch wenn die Peakintensität in den MALDI-Spektren mit jedem Zyklus abnahm. Eine eindeutige Zuordnung der Fingerprints des Antikörpers aus einer Bibliothek von über 90 Antikörpern war trotz dessen gegeben. KW - Korund KW - Immobilisierung KW - Proteomik KW - Rekombinante Proteine KW - Thermostabile Enzyme PY - 2025 SP - 1 EP - 86 CY - Berlin AN - OPUS4-64433 LA - deu AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - CONF A1 - Döring, Sarah T1 - Surface Immobilization of Recombinant Trypsin onto Corundum Particles for Optimized Antibody Digestion N2 - Therapeutic monoclonal antibodies are the fastest-growing class of biological agents and the development of reliable analytical methods for their quantification is becoming increasingly important. Liquid chromatography coupled with tandem mass spectrometry (LC–MS/MS) represents one of the leading technologies for antibody quantification. The serin protease trypsin has emerged as the gold standard enzyme for digesting intact protein into peptides for this approach. However, many protocols exist that often lead to different results depending on the digestion procedure. In particular, the type and amounts of detergents added during sample preparation for protein unfolding before digestion is known to create undesirable structure modifications of proteins (e.g. carbamylation) and significant bias in measurement results by inhibiting enzyme activity. The source and nature of the enzyme itself can also have an influence, whereby immobilized variants are increasingly being used to improve their stability, minimize self-digestion and enable a higher substrate-enzyme ratio. Here, we explored the potential of a novel thermostable trypsin and surface-functionalised corundum particles for enhanced antibody digestion. For this purpose, the inactive zymogen was recombinantly produced in E. coli, activated with enterokinase digestion and finally affinity purified by benzamidine purification. The enzyme activity was analogous to commercially available MS-grade trypsin product. In addition, produced trypsin showed increased thermal stability under typical digestion conditions compared to reference product. Furthermore, APTES-silanization followed by glutaraldehyde modification of corundum surface with an additional blocking step prevents nonspecific protein adsorption during the protein digestion procedure and the immobilized enzyme still showed substrate activity after covalent binding. Compared to wild-type and a non-immobilized enzyme, the surface-functionalized thermostable variant showed increased activity at elevated temperatures. Thus, this novel type of trypsin particles promises to not only improve antibody digestion at high temperatures, but also to prevent self-digestion and enable the separation of trypsin from target peptides in LC–MS analysis. T2 - ANAKON 2025 CY - Leipzig, Germany DA - 10.03.2025 KW - Antibody Quantification KW - Corundum KW - Enzyme Immobilization KW - LC-MS/MS PY - 2025 AN - OPUS4-63480 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - CONF A1 - Döring, Sarah T1 - Optimization of Polymer Interface: Novel Surface-functionalized Corundum Particles for Improved Antibody Digestion N2 - Therapeutic monoclonal antibodies are the fastest-growing class of biological agents and the development of reliable analytical methods for their quantification is becoming increasingly important. Liquid chromatography coupled with tandem mass spectrometry (LC–MS/MS) represents one of the leading technologies for antibody quantification. The serin protease trypsin has emerged as the gold standard enzyme for digesting intact protein into peptides for this approach. However, many protocols exist that often lead to different results. The talk will provide a brief introduction to the application of novel thermostable and surface-functionalized trypsin particles for improved antibody digestion as well as initial successes in polymer functionalization of the corundum surface to prevent nonspecific protein adsorption during the digestion procedure. T2 - SALSA Make and Measure 2024: Interfaces CY - Berlin, Germany DA - 11.09.2024 KW - Antibody Quantification KW - Recombinant Enzymes KW - LC-MS/MS KW - Enzyme Immobilisation KW - Surface Functionalisation KW - Corundum PY - 2024 AN - OPUS4-61041 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - GEN A1 - Döring, Sarah T1 - Sequence of Mus Musculus monoclonal IgG2c anti-CCMV Immunoglobulin N2 - We report the full-length nucleotide and amino acid sequences of the light (κ) and heavy chain of the IgG2c anti-CCMV monoclonal antibody (hybridoma clone BAM-CCMV-29-81), generated against Cowpea Chlorotic Mottle Virus (CCMV). Sequencing of hybridoma clone was performed using a cost-effective Sanger-based workflow that includes DNA-level subclass determination and peptide mass fingerprint confirmation. The κ-chain sequence was assigned to IGKV4-6101 / IGKJ101, while the heavy chain was assigned to IGHV2-601 / IGHD1-101 / IGHJ3*01 with IgG2c constant regions from the NOD strain. Both chains were validated against RNA Illumina sequencing, confirming 100% identity. The sequences are available in GenBank under accession numbers PX123807 (κ-chain) and PX123808 (heavy chain). KW - Antibody Sequencing KW - BAM-CCMV-29-81 KW - anti-CCMV-antibody PY - 2025 UR - https://www.ncbi.nlm.nih.gov/nuccore/PX123807 UR - https://www.ncbi.nlm.nih.gov/nuccore/PX123808 PB - National Library of Medicine CY - Bethesda AN - OPUS4-63968 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER -